Carolyn Borders
Speaker Host
Replay available
GE HealthCare Technologies Inc. (NASDAQ: GEHC) Q4 2025 earnings conference call, held 2026-02-04. Replay captured from the company's public earnings webcast.

Speaker Host
President and CEO
Vice President and CFO
Analyst
Analyst, Wells Fargo
Analyst, PTIG
Analyst, Goldman Sachs
Analyst, Evercore ISI
Good day, and thank you for standing by. Welcome to GE Healthcare Fourth Quarter 2025 Earnings Conference Call. At this time, all participants are on a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. Please note that today's conference is being recorded. I will now turn the call over to your speaker host for today, Carolyn Borders, please go ahead. Thanks, operator. Good morning, and welcome to GE Healthcare's fourth quarter and full year 2025 earnings call. I'm joined by our president and CEO, Peter Arduini, and vice president and CFO, Jay Saccaro. Our conference call remarks will include both GAAP and non-GAAP financial results. Reconciliations between GAAP and non-GAAP measures can be found in today's press release and in the presentation slides available on our website. During this call, we'll make forward-looking statements about our performance. These statements are based on how we see things today. As described in our SEC filings, actual results may differ materially due to risks and uncertainties. With that, I'll hand the call over to Peter. Thanks, Caroline. Good morning, and thank you for joining us. As I look back on our performance in 2025, our third year as a public company, I'm incredibly proud of the meaningful progress that we're making on our innovation renaissance to deliver for our customers and improve patient lives. In the fourth quarter, we delivered strong financial performance above our expectations. This included double-digit organic revenue growth and pharmaceutical diagnostics and mid-single-digit growth in imaging and advanced visualiza...